Wright Medical Group N.V. (WMGI) to Release Quarterly Earnings on Wednesday
Wright Medical Group N.V. (NASDAQ:WMGI) is set to announce its earnings results after the market closes on Wednesday, November 1st. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. Wright Medical Group N.V. has set its FY17 guidance at ($0.26-0.33) EPS.
Wright Medical Group N.V. (NASDAQ:WMGI) last posted its quarterly earnings results on Wednesday, August 2nd. The medical device company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02. The company had revenue of $179.69 million for the quarter, compared to analysts’ expectations of $178.17 million. Wright Medical Group N.V. had a negative net margin of 36.04% and a negative return on equity of 6.22%. Wright Medical Group N.V.’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.11) EPS. On average, analysts expect Wright Medical Group N.V. to post $-0.29 EPS for the current fiscal year and $0.07 EPS for the next fiscal year.
Shares of Wright Medical Group N.V. (WMGI) opened at 25.94 on Wednesday. The company’s market cap is $2.71 billion. Wright Medical Group N.V. has a 12-month low of $20.50 and a 12-month high of $31.53. The company has a 50 day moving average of $26.76 and a 200-day moving average of $27.62.
A number of brokerages recently weighed in on WMGI. BidaskClub upgraded shares of Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Jefferies Group LLC restated a “buy” rating and set a $33.00 price objective on shares of Wright Medical Group N.V. in a research report on Friday, August 4th. Piper Jaffray Companies restated a “buy” rating and set a $34.00 price objective on shares of Wright Medical Group N.V. in a research report on Thursday, August 3rd. Royal Bank Of Canada restated a “buy” rating and set a $31.00 price objective on shares of Wright Medical Group N.V. in a research report on Tuesday, October 3rd. Finally, Needham & Company LLC restated a “hold” rating on shares of Wright Medical Group N.V. in a research report on Friday, September 1st. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Wright Medical Group N.V. has an average rating of “Buy” and an average target price of $32.20.
About Wright Medical Group N.V.
Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.
Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.